Transoral robotic surgery (TORS) is expanding to include patients with HPV-related cancers.
Rates of Post-Transoral Robotic Surgery Hemorrhage Are Low
Although the incidence of post-TORS hemorrhage is low, large tumors, perioperative anti-coagulation, and prior radiation are associated with significantly increased risk of this event.
TORS Use in Early Stage Oropharyngeal Cancer May Lower Positive Margin Outcome
The advantages of TORS for early stage OPSCC may be a lower likelihood of postsurgical positive margins and subsequent need for adjuvant chemoradiotherapy.
UAS Successful Treatment for OSA When Compared with TORS
Upper airway stimulation (UAS) is successful in treating obstructive sleep apnea (OSA) showing improved outcomes, length of stay, and readmission compared to transoral robotic surgery (TORS).
TORS Base of Tongue Surgery Reduces Sleepiness, AHI in OSA
TORS BOT reduction decreases AHI and symptoms of sleepiness in adult patients with OSA
Few Outcome Differences, Higher Costs for DISE and TORS to Treat OSA
Patients who underwent UPPP±T without DISE did not show a statistically significant difference in outcomes compared to the patients who underwent DISE with other procedures, including TORS
Transoral Robotic-Assisted Surgery Safe for Benign Indications
TORS deemed safe, effective for lingual tonsillectomy, base of tongue resection procedures in benign diseases, including obstructive sleep apnea
Rapid Discharge, Oral Diet Not Associated with Post-Operative Complications
How effective is an algorithm for rapid discharge after transoral robotic surgery (TORS), and what is its effect on postoperative complications?
Transoral Robotic Surgery, Intensity-Modulated Radiotherapy Offer Comparable Survival Estimates for Early T-Stage Oropharyngeal Cancer
How do survival estimates for transoral robotic surgery (TORS) compare to intensity-modulated radiotherapy (IMRT) for early T-stage oropharyngeal cancer?